CAD 0.37
(1.39%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 182.69 Million USD | 3.32% |
2022 | 150.47 Million USD | 59.8% |
2021 | 94.16 Million USD | 24.56% |
2020 | 75.59 Million CAD | 21.17% |
2019 | 62.38 Million CAD | 151.42% |
2018 | 24.81 Million CAD | 295.43% |
2017 | 6.27 Million CAD | 623.8% |
2016 | 866.93 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 30.17 Million USD | -33.64% |
2024 Q1 | 37.77 Million USD | 0.17% |
2023 Q4 | 37.7 Million USD | -4.05% |
2023 Q1 | 37.5 Million USD | -6.89% |
2023 Q2 | 40.93 Million USD | 9.13% |
2023 Q3 | 39.29 Million USD | -3.99% |
2023 FY | 155.46 Million USD | 3.32% |
2022 Q3 | 38.38 Million CAD | -11.55% |
2022 Q1 | 28.56 Million CAD | -3.65% |
2022 FY | 150.47 Million USD | 59.8% |
2022 Q4 | 40.28 Million CAD | 4.95% |
2022 Q2 | 43.39 Million CAD | 51.9% |
2021 Q4 | 29.64 Million CAD | 42.92% |
2021 FY | 94.16 Million USD | 24.56% |
2021 Q3 | 20.74 Million CAD | 0.0% |
2020 FY | 75.59 Million CAD | 21.17% |
2019 FY | 62.38 Million CAD | 151.42% |
2018 FY | 24.81 Million CAD | 295.43% |
2017 FY | 6.27 Million CAD | 623.8% |
2016 FY | 866.93 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aurora Cannabis Inc. | 158.53 Million CAD | -15.236% |
Avicanna Inc. | 14.59 Million CAD | -1152.04% |
Avant Brands Inc. | 5.65 Million CAD | -3128.38% |
Cardiol Therapeutics Inc. | 29.53 Million CAD | -518.523% |
Crescita Therapeutics Inc. | 12.32 Million CAD | -1382.906% |
Knight Therapeutics Inc. | 155.54 Million CAD | -17.456% |
MediPharm Labs Corp. | 23.08 Million CAD | -691.466% |
OrganiGram Holdings Inc. | 277.81 Million CAD | 34.238% |
Canopy Growth Corporation | 308.61 Million CAD | 40.801% |
Willow Biosciences Inc. | 7.55 Million CAD | -2318.507% |
Auxly Cannabis Group Inc. | 40.28 Million CAD | -353.538% |